Peptides and obesity: The PYY3-36 story

Regulatory Peptides

Volumn 119, Issue 1-2, 2004, Pages 1-2

  Park, Adrian ^a   Bloom, Stephen R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; DIPEPTIDYL PEPTIDASE IV; NEUROPEPTIDE Y; PEPTIDE DERIVATIVE; PEPTIDE YY [3-36]; PROOPIOMELANOCORTIN; UNCLASSIFIED DRUG; PEPTIDE; PEPTIDE YY; PEPTIDE YY (3 36); PEPTIDE YY (3-36);

ANOREXIA; ANTERIOR HYPOTHALAMUS; BODY MASS; BREAST CANCER; CALORIC INTAKE; CARDIOVASCULAR DISEASE; COLON CANCER; EDITORIAL; ENDOMETRIUM CANCER; EPIDEMIC; GALLBLADDER DISEASE; HUMAN; HYPERTENSION; INCIDENCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSTEOARTHRITIS; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; RESPIRATORY TRACT DISEASE; RISK FACTOR; SLEEP APNEA SYNDROME; STROKE; WORLD HEALTH ORGANIZATION; ANIMAL; APPETITE; BRAIN; CENTRAL NERVOUS SYSTEM; CHEMISTRY; DRUG EFFECT; EATING; PATHOLOGY;

AGOUTI;

ANIMALS; APPETITE; BODY MASS INDEX; BRAIN; CENTRAL NERVOUS SYSTEM; EATING; HUMANS; OBESITY; PEPTIDE YY; PEPTIDES;

EID: 1842785720     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2004.02.006     Document Type: Editorial

References (18)

1. Allison D.B., Fontaine K.R., Manson J.E., Stevens J., VanItallie T.B. Annual deaths attributable to obesity in the United States. JAMA. 282(16):1999;1530-1538.
2. National Center for Health Statistics CfDC Prevalence of overweight and obesity among adults: United States. 1999;Hyattsville, Maryland, USA.
3. WHO Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. 1998;WHO, Geneva, Switzerland.
4. United States Department of Health and Human Services The Surgeon General's call to action to prevent and decrease overweight and obesity. 2001;US Department of Health and Human Services, Public Health Service, Office of the Surgeon General, Rockville, MD. Ref Type: Generic.
5. Druce M., Bloom S.R. Central regulators of food intake. Curr. Opin. Clin. Nutr. Metab. Care. 6(4):2003;361-367.
6. Tatemoto K. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc. Natl. Acad. Sci. U. S. A. 79(8):1982;2514-2518.
7. De M.I., Korom S., Van Damme J., Scharpe S. CD26, let it cut or cut it down. Immunol. Today. 20(8):1999;367-375.
8. Adrian T.E., Ferri G.L., Bacarese-Hamilton A.J., Fuessl H.S., Polak J.M., Bloom S.R. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology. 89(5):1985;1070-1077.
9. El Salhy M., Suhr O., Danielsson A. Peptide YY in gastrointestinal disorders. Peptides. 23(2):2002;397-402.
10. Adrian T.E., Savage A.P., Fuessl H.S., Wolfe K., Besterman H.S., Bloom S.R. Release of peptide YY (PYY) after resection of small bowel, colon, or pancreas in man. Surgery. 101(6):1987;715-719.
11. Adrian T.E., Savage A.P., Bacarese-Hamilton A.J., Wolfe K., Besterman H.S., Bloom S.R. Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology. 90(2):1986;379-384.
12. Hoentjen F., Hopman W.P., Jansen J.B. Effect of circulating peptide YY on gallbladder emptying in humans. Scand. J. Gastroenterol. 36(10):2001;1086-1091.
13. Savage A.P., Adrian T.E., Carolan G., Chatterjee V.K., Bloom S.R. Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut. 28(2):1987;166-170.
14. Fujimiya M., Inui A. Peptidergic regulation of gastrointestinal motility in rodents. Peptides. 21(10):2000;1565-1582.
15. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L.et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature. 418(6898):2002;650-654.
16. Batterham R.L., Cohen M.A., Ellis S.M., Le Roux C.W., Withers D.J., Frost G.S.et al. Inhibition of food intake in obese subjects by peptide YY3-36. N. Engl. J. Med. 349(10):2003;941-948.
17. Cohen M.A., Ellis S.M., Le Roux C.W., Batterham R.L., Park A., Patterson M.et al. Oxyntomodulin suppresses appetite and reduces food intake in humans. J. Clin. Endocrinol. Metab. 88(10):2003;4696-4701.
18. Batterham R.L., Le Roux C.W., Cohen M.A., Park A.J., Ellis S.M., Patterson M.et al. Pancreatic polypeptide reduces appetite and food intake in humans. J. Clin. Endocrinol. Metab. 88(8):2003;3989-3992.